I provide allogeneic (donor-provided) blood or marrow stem cell transplants for the treatment of leukemias, lymphomas, and selected solid tumors in adult patients. In the laboratory, I am investigating ways to use dendritic cells — a specific type of white blood cell — to activate the immune system to destroy cancer cells and viruses. Part of my research involves understanding how immature blood cells develop into dendritic cells and how dendritic cells interact with other immune cells, including T cells. I am also studying the effectiveness of using dendritic cells to reduce the risk of graft-versus-host disease in transplant patients (a condition in which T cells from the donor marrow attack the recipient’s tissues). My colleagues and I are also evaluating the use of dendritic cell-based vaccines against cancer.
- Clinical Expertise: Bone Marrow Transplantation; Hematology and Hematologic Malignancies; Immunology and Immunotherapy
- Languages Spoken: English
- Education: MD, Vanderbilt University School of Medicine
- Residencies: Internal Medicine - Johns Hopkins Hospitak/Osler Medical Center
- Fellowships: Rheumatic Diseases - Hospital for Special Surgery; Hematology/Oncology - New York Hospital
- Board Certifications: Internal Medicine; Medical Oncology; Hematology; Rheumatology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Co-Investigated by James W. Young
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more